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What are ATM and ATR? Ataxia
telangiectasia mutated (ATM) and
ATM and RAD3-related (ATR) are
members of the phosphatidyl-
inositol 3-kinase (PI 3-kinase) like
family of protein kinases (PIKKs).
These large proteins — predicted
molecular masses for ATM and
ATR are 351 kDa and 301 kDa,
respectively — are involved in
cellular responses to DNA damage. 
Don’t ever say… That ATM and
ATR phosphorylate lipids! Despite
a marked similarity between their
carboxy-terminal kinase domains
and those of PI 3-kinases, ATM
and ATR seem to phosphorylate
proteins exclusively.
Not to be confused with... Cash
dispensers or the anthrax toxin
receptor!
What do ATM and ATR do in the
cell? To maintain genomic
stability in the face of constant
exposure to exogenous and
endogenous DNA-damaging
agents, all eukaryotic cells contain
elaborate, highly conserved
pathways to sense, signal and
repair DNA damage. ATM and
ATR act near the top of these
signalling networks. Their role
here is so important that they have
been described as ‘sentries at the
gate of genome stability’.
But what exactly do they do?
DNA damage caused by ionising
radiation (double-strand DNA
breaks) somehow activates the
kinase activity of ATM (see below).
ATR kinase activity is activated
primarily in response to a different
set of DNA lesions, including those
caused by UV light, and in
response to stalled replication
forks. Once activated, ATM and
ATR phosphorylate an overlapping
set of DNA repair/checkpoint
targets. For ATM these include
p53, CHK2, NBS1 and BRCA1.
Targets for ATR include p53 and
CHK1. One important effect of
these phosphorylation events is the
control of cell-cycle checkpoints
(but see the figure for other
essential effects). Depending on
the nature of the DNA lesion, both
ATM and ATR can induce the G1/S,
G2/M and S-phase checkpoints.
By doing so, they ensure that the
cell accurately repairs the DNA
damage before DNA replication or
cell division occurs.
How do ATM and ATR detect
DNA damage? ATM and ATR can
be activated in response to one or
a handful of DNA lesions in the
cell but how is this sensitivity
achieved? In the case of ATR (and
its S. cerevisiae and S. pombe
orthologues, Mec1p and SpRad3,
respectively), the ability to
phosphorylate downstream
substrates requires an associated
protein (ATRIP for ATR; Lcd1p and
SpRad26 for S. cerevisiae and S.
pombe, respectively). The search
is now on for a similar subunit for
ATM. Meanwhile, a paper by
Bakkenist and Kastan provides
intriguing insights into early
events in ATM activation as shown
in the figure.
Can we live without ATM and
ATR? Yes and no. In ataxia-
telangiectasia, the lack of a
functional copy of ATM is
associated with progressive
neurodegeneration,
immunodeficiency, predisposition
to malignancy and radiation
sensitivity. People who are
heterozygous for ATM mutations
have a slightly increased incidence
of cancer. No human disease has
yet been associated with total loss
of ATR and mice engineered to
lack ATR expression die as
embryos. However, partial loss of
ATR activity has recently been
associated with the human
autosomal recessive disorder
Seckel syndrome.
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Figure 1. A possible model for the early
events in ATM activation. In cells with
undamaged DNA (1), ATM exists as
dimers/multimers in which the active site
is blocked. Double-strand DNA breaks (2)
lead to ATM intermolecular phosphoryla-
tion (yellow), dissociation of the
dimer/multimer and exposure of the
kinase domain (3). ATM is then thought to
be targeted to DNA lesions via adaptor(s)
(4). Focus formation follows the phospho-
rylation of ATM targets (such as p53, red).
The cellular outcome depends on whether
successful DNA repair occurs.
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